BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25692087)

  • 1. Reticular telangiectatic erythema: case report and literature review.
    Beutler BD; Cohen PR
    Dermatol Pract Concept; 2015 Jan; 5(1):71-5. PubMed ID: 25692087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telangiectatic erythematous cutaneous reaction to an implantable cardioverter defibrillator.
    Ferringer T; Mowad C
    Am J Contact Dermat; 2003 Mar; 14(1):37-40. PubMed ID: 14744422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reticular telangiectatic erythema associated with an implantable cardioverter defibrillator.
    Pitarch G; Mercader P; Torrijos A; Martínez-Menchón T; Fortea JM
    Cutis; 2006 Nov; 78(5):329-31. PubMed ID: 17186791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reticular telangiectatic erythema by breast implants.
    Tostón NS; Migueláñez MM; Tornero LP; Martínez SDC; Santos-Briz A; Curto CR
    JPRAS Open; 2021 Mar; 27():7-11. PubMed ID: 33294578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-implantation erythema in 3 patients and a review of reticular telangiectatic erythema.
    Aneja S; Taylor JS; Billings SD; Honari G; Sood A
    Contact Dermatitis; 2011 May; 64(5):280-8. PubMed ID: 21480914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticular telangiectatic erythema associated with an implantable cardioverter defibrillator.
    Dinulos JG; Vath B; Beckmann C; Welch MP; Piepkorn M
    Arch Dermatol; 2001 Sep; 137(9):1259-61. PubMed ID: 11559237
    [No Abstract]   [Full Text] [Related]  

  • 7. Reticular telangiectatic erythema associated with an implantable cardioverter defibrillator: an underpublished entity?
    Herbst RA; Weiss J
    Arch Dermatol; 2003 Jan; 139(1):100-1. PubMed ID: 12533181
    [No Abstract]   [Full Text] [Related]  

  • 8. Reticular telangiectatic erythema associated with implantable automatic cardioverter defibrillator.
    Calderón-Castrat X; Cañueto J; Román-Curto C; Santos-Briz Á; Fernández-López E
    Indian J Dermatol Venereol Leprol; 2018; 84(3):334-336. PubMed ID: 29451140
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypersensitivity reactions to implantable cardiac pacemakers and defibrillators].
    Kreft B
    Hautarzt; 2016 May; 67(5):352-8. PubMed ID: 26943358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiosarcoma-like presentation of pacemaker-related vascular proliferation.
    Ringrose JS; Banerjee T; Hull PR
    Clin Exp Dermatol; 2012 Mar; 37(2):143-5. PubMed ID: 22106983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythema and swelling after im-plantation of a cardioverter defibrillator (ICD)].
    Kreft B; Thomas P; Steinhauser E; Vass A; Summer B; Wohlrab J
    Dtsch Med Wochenschr; 2015 Sep; 140(19):1462-4. PubMed ID: 26402185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead Macrodislodgement of a Subcutaneous Implantable Cardioverter-Defibrillator Results in a Reel Problem.
    El-Zein RS; Shah A; Luli J; Stelzer M; Fu E; Amin AK
    JACC Case Rep; 2021 Mar; 3(3):523-527. PubMed ID: 34317572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent telangiectatic erythema associated with an automatic implantable cardioverter defibrillator.
    Krasagakis K; Vogt R; Tebbe B; Goerdt S
    Br J Dermatol; 1997 Apr; 136(4):633. PubMed ID: 9155977
    [No Abstract]   [Full Text] [Related]  

  • 15. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.
    Knops RE; Olde Nordkamp LR; de Groot JR; Wilde AA
    Heart Rhythm; 2013 Aug; 10(8):1240-3. PubMed ID: 23707489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
    Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
    Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
    Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
    Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reticulated telangiectatic erythema of the pacemaker.
    Martin LK; Wendschuh P; Wendschuh P
    Pacing Clin Electrophysiol; 2008 May; 31(5):624-6. PubMed ID: 18439182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation Techniques.
    Brouwer TF; Miller MA; Quast AB; Palaniswamy C; Dukkipati SR; Reddy V; Wilde AA; Willner JM; Knops RE
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):e004663. PubMed ID: 28073910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.